Liquid-based e-cigarettes emit 12 times more ultrafine dust than regular cigarettes, according to a recent study by the Korea Disease Control and Prevention Agency.
By photographing smoke and aerosols emitted from cigarettes to analyze their chemical composition, the results showed that liquid-based e-cigarettes emitted 172,845 micrograms (㎍) of ultrafine dust per 0.2 grams of liquid, 12 times more than what was emitted by non-electronic cigarettes.
Meanwhile, heated e-cigarettes emitted 3,100 ㎍ of ultrafine dust per cigarette, lower than emissions from non-electronic cigarettes.
Over a three-minute period, the ultrafine dust emitted by liquid-based e-cigarettes spread as far as 10 meters, heated e-cigarettes to between 6 and 7 meters and non-electronic cigarettes to 3 meters.
The study also revealed that black carbon, a chemical related to the automobile emissions stains, is released by all three types of cigarettes.
The highest black carbon levels were from non-electronic cigarettes, which were also present in liquid-based e-cigarettes (98.8 ㎍ per piece) and heated e-cigarettes (11.41 ㎍ per piece).
h invites itself on the King Platinum.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 



